Cited by 200Virus-based gene therapy researchRNA Interference and Gene DeliveryCRISPR and Genetic Engineering

A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation

Duan, Dongsheng, Yue, Yongping, Yan, Ziying, Engelhardt, John F.·2000·Nature Medicine

Integrity signals

Registry

Crossref · 10.1038/75080

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Split vector systems exploiting head-to-tail concatamerization have been developed to circumvent the small packaging capacity of AAV genomes.

    “Recently, split vector systems, exploiting head-to-tail concatamerization formation, have been developed to circumvent the small packaging capacity of AAV genomes (13-16, 41, 52).”
  • The trans-splicing method to expand the size of ORFs that can be successfully expressed using AAV vectors was originally developed in the laboratory of John Engelhardt and has since been utilized in several studies with varying success.

    “The trans-splicing method to expand the size of ORFs that can be successfully expressed using AAV vectors was originally developed in the laboratory of John Engelhardt 52,53 and has since been utilized in several studies with varying success (e.g., refs. 53-57 ).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Duan, D., Yue, Y., Yan, Z., & Engelhardt, J. F.
Affiliations
University of Iowa (US)
Corresponding author
Engelhardt, John F.
Venue
Nature Medicine
Published
2000-05
Volume
6
Issue
5
Pages
595-598
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W1582366477
Cited by
200
References
1
Citations by year
2026: 5 · 2025: 10 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 1 · 2013: 7 · 2012: 6
FWCI
11.71
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL058340, HL58430)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK054759)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
recombinant adeno-associated virus, cis-acting enhancer, gene expression enhancement, adeno-associated virus vectors, gene therapy
MeSH terms
Dependovirus, Animals, Fibroblasts, Gene Expression Regulation, Genetic Vectors, Humans, Nucleic Acid Conformation, Recombinant Proteins, Gene Transfer Techniques, Muscle, Skeletal, Transgenes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review